Steroidal Antiestrogen Fulvestrant Anti Cancer Drug WC Avai 129453-61-8
Contact Person : Jimmy Tian
Phone Number : 86-18602905046
WhatsApp : +8618602905046
Detail Information |
|||
Pack Size: | 1 Vial | Administration: | Intramuscular |
---|---|---|---|
Product Name: | Fulvestrant | Contraindications: | Hypersensitivity To The Active Substance Or To Any Of The Excipients |
Active Ingredient: | Fulvestrant | Strength: | 500mg/5ml |
Dosage: | 250mg Intramuscularly Once Every 28 Days | Adverse Reactions: | Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia |
High Light: | 5ml Faslodex Injection,Faslodex Intramuscular Injection Administration |
Product Description
Faslodex Injection 250mg is a once every 28 days intramuscularly administered medication, containing the active ingredient Fulvestrant, manufactured by Pfizer. It is used for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. This medication should not be taken by patients who have hypersensitivity to the active substance or to any of the excipients.
Faslodex Injection 250mg has a shelf life of 36 months, and is designed to be used in combination with other medications in the treatment of breast cancer. It works by blocking the activity of the hormone oestrogen, which is known to stimulate the growth of cancer cells. This medication is typically used in postmenopausal women, as oestrogen is no longer naturally produced in sufficient quantities for normal functioning.
Faslodex Injection 250mg is a powerful and effective medication in the treatment of hormone receptor-positive metastatic breast cancer. It is manufactured by Pfizer, and should not be taken by patients with hypersensitivity to the active substance or to any of the excipients.
Attribute | Detail |
---|---|
Adverse Reactions | Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia |
Dosage | 250mg Intramuscularly Once Every 28 Days |
Pack Size | 1 Vial |
Manufacturer | Pfizer |
Administration | Intramuscular |
Storage Conditions | Store At Room Temperature |
Form | Injection |
Contraindications | Hypersensitivity To The Active Substance Or To Any Of The Excipients |
Shelf Life | 36 Months |
Warnings | Do Not Use In Pregnant Or Breastfeeding Women |
Fulvestrant Injection is an active ingredient used for the treatment of hormone receptor-positive metastatic breast cancer. It is available in a single-use vial as Faslodex Injection. The injection should be stored at room temperature and has a shelf life of 36 months. It should not be used if the patient has hypersensitivity to the active substance or any of the excipients.
This medication is used to treat hormone receptor-positive metastatic breast cancer, which is a type of cancer that has spread to other parts of the body. Fulvestrant Injection is a hormone therapy that works by blocking the action of estrogen in the body. It is usually used in combination with other medications and is given as a once-monthly injection.
Faslodex Injection is an effective treatment for hormone receptor-positive metastatic breast cancer and offers several advantages. It has the ability to reduce the size of the tumor, slow down the growth of the cancer, and prevent the cancer from spreading. It is also well-tolerated and has minimal side effects. Patients may experience some temporary pain or discomfort at the injection site, but this should dissipate within a few days.
Fulvestrant Injection is a safe and effective treatment for hormone receptor-positive metastatic breast cancer. It is important for patients to follow their doctor’s instructions and to take the medication as prescribed. Patients should also inform their doctor if they experience any side effects or other problems while taking this medication.
Fulvestrant Technical Support and Services include:
Enter Your Message